So, IF Some Entity Currently Owns/Controls "Non-Voting BrokerShares"...
of say 100million shares, then we need to consider some possibilities.
Perhaps they are trying to force PPHM to partner or sell company to them at their price or terms? Manipulation of PPS to strong arm corporate mergers is of course illegal, but I'm sure if that was being done there would not be 1 account sitting at 1 broker listed for 1 BP or Family. With the SEC, if you can't prove there is a crime... then there is no crime.
Perhaps they are trying to prevent PPHM from having viable financing to go it alone? Well, with a RS and not reducing the Shelf, PPHM would regain high dollar financing via ATM, especially including the preferred PPHMP shares which also was noted that they would not reduced approved number of shares that have not been issued yet, but could be issued at 7 times current value after split!
Perhaps PPHM knows one entity is behind all those Non-Voting BrokerShares and a new BP is interested in partnering/buying. As Biopharm pointed out, a RS scenario could certainly be used to decrease the percentage of the company held by those "Non-Voting BrokerShares" and enable PPHM to allow new BP to buy a much larger position after the RS then current volume of "Non-voting BrokerShares" represent while reducing current owners percentage of shares.
Another option is that a potential deal is in place because despite there not being enough data currently disclosed that would allow FDA approval, there is a distinct possibility that there is enough data that has been shared via negotiation tables that would cause a potential buyer to be interested in closing a deal with cash plus 1 share of their stock per share of PPHM, BUT a RS would reduce the number of shares they would have to produce. Lower number of shares would be easier for buying company to get approved via their bottom line!!!
Also, IF one Entity does indirectly own controlling interest in all those "Non-Voting BrokerShares", they may not want PPHM to do a RS which would cause their hypothetical large position to be reduced after a RS if PPHM would issue large volume of shares to a new partner... so, that Entity could decide to make a better offer and close a deal before PPHM can transact a RS!
Many companies are bought and sold without having a current FDA approved product on the market. We must acknowledge that negotiations between PPHM and potential buyers would allow them to discuss data that we may never see! Certainly a BP could simply want to buy PPHM to make sure PS technology never sees the light of day so their products are assured a future?!!
There are many other possible scenarios, but one that can't be denied, without having any other facts then what is currently available, is that some might want to squash PPHM's PPS out of existence. Legal? No, but what is millions of dollars of loss compared to trillions of future gains by a BP? Insignificant...
None the less, I am still banking on PS, BetaBodies, Cancer Blood Test, No Debt, Unencumbered Pipeline, Dart, Vanguard, KennedyFunds, etc., etc.
Almost every PR since 2012 has been Positive yet produced a negative PPS move... Coincidence or Manipulation?
Glta StockHOLDERS and NewInvestors!
Market Data 
Markets 
AI
